SAN FRANCISCO—After securing FDA clearance for its G7 continuous glucose monitor system last month, Dexcom is ready to begin adding the U.S. to its list of launch sites across the globe this quarter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback